138 related articles for article (PubMed ID: 8535400)
1. Inhibitory effect of pyridobenzazoles on virus replication in vitro.
Chiba T; Shigeta S; Numazaki Y
Biol Pharm Bull; 1995 Aug; 18(8):1081-3. PubMed ID: 8535400
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of antiviral compounds on respiratory syncytial virus replication in vitro.
Kawana F; Shigeta S; Hosoya M; Suzuki H; De Clercq E
Antimicrob Agents Chemother; 1987 Aug; 31(8):1225-30. PubMed ID: 3307618
[TBL] [Abstract][Full Text] [Related]
3. The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro.
Balzarini J; Neyts J; Schols D; Hosoya M; Van Damme E; Peumans W; De Clercq E
Antiviral Res; 1992 Jun; 18(2):191-207. PubMed ID: 1329650
[TBL] [Abstract][Full Text] [Related]
4. Protective action of benzimidazole derivatives against virus infections in tissue culture and in vivo.
O'Sullivan DG; Pantic D; Dane DS; Briggs M
Lancet; 1969 Mar; 1(7592):446-8. PubMed ID: 4179506
[No Abstract] [Full Text] [Related]
5. A novel p38 mitogen activated protein kinase (MAPK) specific inhibitor suppresses respiratory syncytial virus and influenza A virus replication by inhibiting virus-induced p38 MAPK activation.
Choi MS; Heo J; Yi CM; Ban J; Lee NJ; Lee NR; Kim SW; Kim NJ; Inn KS
Biochem Biophys Res Commun; 2016 Aug; 477(3):311-6. PubMed ID: 27346133
[TBL] [Abstract][Full Text] [Related]
6. [Studies on antiviral agents. I. Antiviral activity of pyridobenzoazoles].
Shigeta S; Hosoya M; Mochizuki S; Chiba T
Yakugaku Zasshi; 1988 Sep; 108(9):856-9. PubMed ID: 2854557
[No Abstract] [Full Text] [Related]
7. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses.
Ohol YM; Wang Z; Kemble G; Duke G
PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560
[TBL] [Abstract][Full Text] [Related]
8. Substituted benzimidazoles with nanomolar activity against respiratory syncytial virus.
Andries K; Moeremans M; Gevers T; Willebrords R; Sommen C; Lacrampe J; Janssens F; Wyde PR
Antiviral Res; 2003 Nov; 60(3):209-19. PubMed ID: 14638397
[TBL] [Abstract][Full Text] [Related]
9. Potent inhibition of respiratory syncytial virus by polyoxometalates of several structural classes.
Barnard DL; Hill CL; Gage T; Matheson JE; Huffman JH; Sidwell RW; Otto MI; Schinazi RF
Antiviral Res; 1997 Mar; 34(1):27-37. PubMed ID: 9107383
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory effects of several antiviral compounds on the replication of respiratory syncytial virus in vitro.
Kawana F; Shigeta S; De Clercq E
Antiviral Res; 1985; Suppl 1():83-8. PubMed ID: 4083870
[No Abstract] [Full Text] [Related]
11. Inhibition of Respiratory syncytial, parainfluenza 3 and measles viruses by 2-deoxy-D-glucose.
Hodes DS; Schnitzer TJ; Kalica AR; Camargo E; Chanock RM
Virology; 1975 Jan; 63(1):201-8. PubMed ID: 163047
[No Abstract] [Full Text] [Related]
12. Inhibition of respiratory syncytial virus by bis(5-amidino-2-benzimidazolyl)methane.
Dubovi EJ; Geratz JD; Tidwell RR
Virology; 1980 Jun; 103(2):502-9. PubMed ID: 6247826
[No Abstract] [Full Text] [Related]
13. YM-53403, a unique anti-respiratory syncytial virus agent with a novel mechanism of action.
Sudo K; Miyazaki Y; Kojima N; Kobayashi M; Suzuki H; Shintani M; Shimizu Y
Antiviral Res; 2005 Feb; 65(2):125-31. PubMed ID: 15708639
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028).
Sudo K; Konno K; Watanabe W; Shigeta S; Yokota T
Microbiol Immunol; 2001; 45(7):531-7. PubMed ID: 11529559
[TBL] [Abstract][Full Text] [Related]
15. [The anti-respiratory syncytial virus (RSV) effect of Radix Glycyrrhizae in vitro].
Dong Y; Li H; Yao Z; Tian W; Han Z; Qiu H; Piao Y
Zhong Yao Cai; 2004 Jun; 27(6):425-7. PubMed ID: 15524297
[TBL] [Abstract][Full Text] [Related]
16. Respiratory syncytial virus inhibitors. Part 2: Benzimidazol-2-one derivatives.
Yu KL; Zhang Y; Civiello RL; Trehan AK; Pearce BC; Yin Z; Combrink KD; Gulgeze HB; Wang XA; Kadow KF; Cianci CW; Krystal M; Meanwell NA
Bioorg Med Chem Lett; 2004 Mar; 14(5):1133-7. PubMed ID: 14980651
[TBL] [Abstract][Full Text] [Related]
17. Novel anti-respiratory syncytial(RS) viral compounds: benzodithiin derivatives.
Watanabe W; Sudo K; Sata R; Kajiyashiki T; Konno K; Shigeta S; Yokota T
Biochem Biophys Res Commun; 1998 Aug; 249(3):922-6. PubMed ID: 9731237
[TBL] [Abstract][Full Text] [Related]
18. [Study of the effect of antiviral drugs on the reproduction of the respiratory syncytial virus by enzyme immunoassay].
Leneva IA; Sokolova MV; Fediakina IT; Khristova ML; Fadeeva NI; Gus'kova TA
Vopr Virusol; 2002; 47(2):42-5. PubMed ID: 12046469
[TBL] [Abstract][Full Text] [Related]
19. Replication-Competent Influenza Virus and Respiratory Syncytial Virus Luciferase Reporter Strains Engineered for Co-Infections Identify Antiviral Compounds in Combination Screens.
Yan D; Weisshaar M; Lamb K; Chung HK; Lin MZ; Plemper RK
Biochemistry; 2015 Sep; 54(36):5589-604. PubMed ID: 26307636
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of action of the antiherpesvirus biflavone ginkgetin.
Hayashi K; Hayashi T; Morita N
Antimicrob Agents Chemother; 1992 Sep; 36(9):1890-3. PubMed ID: 1329635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
